Heron Therapeutics (HRTX) Capital Expenditures (2010 - 2026)
Heron Therapeutics (HRTX) posted Capital Expenditures of $138,000 for Q2 2026, down 33.7% from $208,000 a year earlier and down 64.7% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Capital Expenditures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Heron Therapeutics was $529,000, down 61.8% year-over-year; for FY2025, it came in at $317,000, down 81.4% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -45.9% (FY2020 to FY2025).
- In prior years, Heron Therapeutics' Capital Expenditures was $1.71 million in FY2024 (+10.4%), $1.55 million in FY2023 (-15.3%), $1.83 million in FY2022 (-39.6%) and $3.02 million in FY2021 (-55.6%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q1 2025.
- On a year-over-year basis, Capital Expenditures increased in two of the last four quarters, with growth averaging 83.7%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2026, with growth of 258.7%; the weakest was Q3 2022, with a decline of 97.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn | 138,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 138,000.00 |
| Mar 31, 2026 | 391,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | 431,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Jun 30, 2023 | 278,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Dec 31, 2022 | 414,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 322,000.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 315,000.00 |
| Mar 31, 2021 | 786,000.00 |
| Dec 31, 2020 | 2.49 Mn |
| Sep 30, 2020 | 632,000.00 |
API Access
Heron Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();